fda glp-1 compounding warning letters october 2025 Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility CDER Warning Letters Jump 50%

the exact list is compounder-specific

, Meredith Freed, et al ., More Than Half of All People on Medicare Do Not Compare Their Coverage Options Annually, Kaiser Family Foundation (October 29, 2020), Wyatt Korma, et al., Seven in Ten Medicare Beneficiaries Did Not Compare Plans Past Open Enrollment Period, Kaiser Family Foundation (October 13, 2021), [xxx] Nancy Ochieng, et al., Nearly 7 in 10 Medicare Beneficiaries Did Not Compare Plans During Medicares Open Enrollment Period (September 26, 2024), [xxxi] Medicare Advantage enrollees do have an annual enrollment period running from January 1 through March 31 that they can use to switch to another MA plan or to Original Medicare

doi: 10.2337/diacare.24.4.775 24 MatthewsDRHoskerJPRudenskiASNaylorBATreacherDFTurnerRC

In animal models of neurodegenerative diseases, it has been demonstrated that administration of GLP-1RAs can result in the improvement of mitochondrial stability